Sage Therapeutics, Inc.

GEODE CAPITAL MANAGEMENT, LLC

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/8/2025

Shares

1,356,577

Value ($000)

12,374

Weight

0.0%

2019 Q4 - 2025 Q2 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/8/2025	12,374	0.0%	1,356,577	6/30/2025
2025 Q1	5/13/2025	10,365	0.0%	1,303,377	3/31/2025
2024 Q4	2/12/2025	6,827	0.0%	1,256,903	12/31/2024
2024 Q3	11/12/2024	8,975	0.0%	1,242,854	9/30/2024
2024 Q2	8/9/2024	13,460	0.0%	1,239,097	6/30/2024
2024 Q1	5/13/2024	22,329	0.0%	1,191,331	3/31/2024
2023 Q4	2/13/2024	25,297	0.0%	1,167,257	12/31/2023
2023 Q3	11/13/2023	22,754	0.0%	1,105,513	9/30/2023
2023 Q2	8/11/2023	50,196	0.0%	1,067,545	6/30/2023
2023 Q1	5/15/2023	43,649	0.0%	1,040,245	3/31/2023
2022 Q4	2/13/2023	38,423	0.0%	1,007,430	12/31/2022
2022 Q3	11/14/2022	37,748	0.0%	963,954	9/30/2022
2022 Q2	8/12/2022	30,826	0.0%	954,373	6/30/2022
2022 Q1	5/13/2022	23,722	0.0%	716,682	3/31/2022
2021 Q4	2/11/2022	38,636	0.0%	908,229	12/31/2021
2021 Q3	11/12/2021	38,762	0.0%	874,805	9/30/2021
2021 Q2	8/13/2021	43,952	0.0%	773,684	6/30/2021
2021 Q1	5/12/2021	49,211	0.0%	657,464	3/31/2021
2020 Q4	2/12/2021	55,200	0.0%	638,087	12/31/2020
2020 Q3	11/13/2020	36,757	0.0%	601,400	9/30/2020
2020 Q2	8/13/2020	25,796	0.0%	620,400	6/30/2020
2020 Q1	5/14/2020	17,095	0.0%	595,242	3/31/2020
2019 Q4	2/13/2020	41,260	0.0%	571,557	12/31/2019